05-21022. National Heart, Lung, and Blood Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Research Project (Cooperative Agreement) Applications

    Date: November 15, 2005.

    Time: 1 p.m. to 3 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

    Contact Person: Shelley S. Sehnert, PhD, Scientific Review Administrator, Review Branch, NIH/NHLBI, 6701 Rockledge Drive, Room 7206, Bethesda, MD 20892-7924, 301/435-0303, ssehnert@nhlbi.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Research Project Grant Applications (R01s)

    Date: November 17, 2005.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

    Contact Person: YingYing Li-Smerin, PhD, MD, Scientific Review Administrator, Division of Extramural Affairs, Review Branch, National Heart, Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20814, 301/435-0275, lismerin@nhlbi.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

    Start Signature

    Dated: October 11, 2005.

    Anthony M. Coelho, Jr.,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 05-21022 Filed 10-19-05; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Comments Received:
0 Comments
Effective Date:
11/15/2005
Published:
10/20/2005
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
05-21022
Dates:
November 15, 2005.
Pages:
61144-61144 (1 pages)
PDF File:
05-21022.pdf